The C228T and C250T mutations were the most frequent in TERT promoter [77.5% and 20.8% in glioma respectively (34)], inducing a consensus sequence bound by E-Twenty-Six (ETS) transcription factors (35). Here, TERT is linked to central nervous system cancer.